Metformin can inhibit Helicobacter pylori growth - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Future Microbiology Year : 2018

Metformin can inhibit Helicobacter pylori growth


Aim: Helicobacter pylori infection is a worldwide infection, its eradication rates with conventional therapies have fallen to unacceptable levels. In this context we were interested in metformin, to determine its effect on H. pylori growth. Materials & methods: Antimicrobial susceptibility tests and survival curves were performed in vitro and a H. pylori-infected mice model was used to determine metformin effect in vivo. Results: Helicobacter pylori survival and growth were decreased in presence of metformin. Furthermore, metformin-treated mice had significantly less bacteria in their stomach than the untreated mice. Conclusion: Our work is the first to demonstrate a direct antimicrobial effect of metformin on H. pylori, indicating that this molecule has not yet revealed its full potential.
No file

Dates and versions

inserm-03004859 , version 1 (13-11-2020)



Sarah Courtois, Lucie Bénéjat, Julien Izotte, Francis Mégraud, Christine Varon, et al.. Metformin can inhibit Helicobacter pylori growth. Future Microbiology, 2018, 13 (14), pp.1575-1583. ⟨10.2217/fmb-2018-0184⟩. ⟨inserm-03004859⟩


23 View
0 Download



Gmail Facebook X LinkedIn More